Bibliografías temáticas / Pisa syndrome / Artículos de revistas
Siga este enlace para ver otros tipos de publicaciones sobre el tema: Pisa syndrome.

Artículos de revistas sobre el tema "Pisa syndrome"

Autor: Grafiati
Publicado: 11 de marzo de 2023

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Pisa syndrome".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.

1

Uemura, Takeshi, Yuichi Kasai, Kentaro Araki y Atsumasa Uchida. "Pisa Syndrome". Journal of Spinal Disorders & Techniques 21, n.º 6 (agosto de 2008): 455–57. http://dx.doi.org/10.1097/bsd.0b013e3181570889.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Michel, Sáenz Farret, Arias Carrión Oscar, Thalia Estefania Sánchez Correa, Pellene Luis Alejandro y Federico Micheli. "Pisa Syndrome". Clinical Neuropharmacology 38, n.º 4 (2015): 135–40. http://dx.doi.org/10.1097/wnf.0000000000000092.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Stubner, Susanne, Frank Padberg, Renate Grohmann, Harald Hampel, Matthias Hollweg, Hanns Hippius, Hans-Jurgen Moller y Eckart Ruther. "Pisa Syndrome (Pleurothotonus)". Journal of Clinical Psychiatry 61, n.º 8 (15 de agosto de 2000): 569–74. http://dx.doi.org/10.4088/jcp.v61n0805.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Remington, Gary J. "The Pisa Syndrome". Journal of Clinical Psychopharmacology 8, n.º 3 (junio de 1988): 228. http://dx.doi.org/10.1097/00004714-198806000-00025.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Amore, Mario. "THE PISA SYNDROME". Clinical Neuropharmacology 15 (1992): 265B. http://dx.doi.org/10.1097/00002826-199202001-00511.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Harada, Kenichi, Nobuyuki Sasaki, Hiroshi Ikeda, Norihito Nakano, Hiroki Ozawa y Toshikazu Saito. "Risperidone-Induced Pisa Syndrome". Journal of Clinical Psychiatry 63, n.º 2 (15 de febrero de 2002): 166. http://dx.doi.org/10.4088/jcp.v63n0213b.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Mascia, Marcello Mario y Giovanni Defazio. "Cocaine-induced Pisa syndrome". Neurological Sciences 42, n.º 9 (19 de junio de 2021): 3927–28. http://dx.doi.org/10.1007/s10072-021-05404-x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Teng, Po-Ren y Te-Jen Lai. "Paliperidone-Related Pisa Syndrome". Journal of Clinical Psychopharmacology 33, n.º 1 (febrero de 2013): 129–31. http://dx.doi.org/10.1097/01.jcp.0000426181.89572.18.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Smith, Connor, Naomi Gwynn y Jean-Pierre Lindenmayer. "Pisa Syndrome and Aripiprazole". Journal of Clinical Psychopharmacology 40, n.º 1 (2020): 99–101. http://dx.doi.org/10.1097/jcp.0000000000001162.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Lee, Yen-Feng. "Antipsychotic-Induced Pisa Syndrome". Clinical Neuropharmacology 41, n.º 2 (2018): 60–63. http://dx.doi.org/10.1097/wnf.0000000000000274.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
11

PILETTE, WILFRID L. "Pisa Syndrome, or Pleurothotonus". American Journal of Psychiatry 144, n.º 7 (julio de 1987): 969—b—970. http://dx.doi.org/10.1176/ajp.144.7.969-b.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
12

Gutierrez, F., C. Losada, M. López, C. Rozados, J. M. Olivares, M. Calado y C. Cinos. "Pysa syndrome: a case report". European Psychiatry 26, S2 (marzo de 2011): 1243. http://dx.doi.org/10.1016/s0924-9338(11)72948-0.

Texto completo
Resumen
Pisa syndrome is known to be a condition in which there is sustained involuntary flexion of the body and head to one side and slight rotation of the trunk so the person appears to lean like the Leaning Tower of Pisa.The development of Pisa syndrome is most commonly associated with prolonged treatment with antipsychotics. Although less frequently, Pisa syndrome has been reported, in patients who are receiving other medications (such as cholinesterase inhibitors and antiemetics), in those not receiving medication (idiopathic Pisa syndrome) and also patients with neurodegenerative disorders like Alzheimer's disease and multiple system atrophy.We report a case of a 67 year- old male diagnosed with Schizophrenia for 20 years. He has been following a treatment with Clozapine 400 mg/day for 4 years. Amisulpiride was added to the established regimen of antipsychotic and increased during the last month reaching the doses of 600 mg/day. Three weeks later he was observed walking with a tilt toward the right. A first physical examination revealed sustained tonic flexion of the trunk to the right side. No deficits or mental status changes during neurological exploration were shown. We prescribed biperidene hydrochloride therapy. After 24 hour side effects disappeared.As far as we know, no many cases of amisulpride-induced Pisa syndrome in the literature have been reported. This abstract presents a case of amisulpride induced Pisa syndrome.
Los estilos APA, Harvard, Vancouver, ISO, etc.
13

Bicho, M., J. Coelho, C. Peixoto y H. Fontes. "Pisa syndrome – a case report". European Psychiatry 64, S1 (abril de 2021): S800. http://dx.doi.org/10.1192/j.eurpsy.2021.2116.

Texto completo
Resumen
IntroductionPisa Syndrome or pleurothotonus is a form of dystonia and often can arise as a side effect of antipsychotic treatment conditioning high morbidity and limiting management options. Despite the fact that the precise mechanism remains unclear, a neurochemical imbalance in dopaminergic and cholinergic transmission but also in serotoninergic and noradrenergic transmission can be a possible pathophysiologic mechanism, which can lead to changes in the axial axis with abnormal posture and marked lateral trunk flexion and abnormal gait.ObjectivesRegarding a clinical case, the authors intend to review the relevant and current literature on the relationship between psychotropic drugs and Pisa Syndrome.MethodsDescription of a clinical case by consulting databases of current and scientifically relevant articles.ResultsThe clinical case reports a 48-year-old woman with a history of HIV and Substance Use Disorder, hospitalized for unspecific behavioral changes, characterized by mood changes, self-referential, persecutory and somatic delusional ideas, and delusions of the control of thought. She was medicated with antipsychotics and mood stabilizers, with subsequent development of an acute-onset dystonic condition, characterizing the Pisa Syndrome. In this context, the dose of antipsychotics was lowered and anticholinergics were introduced, with progressive improvement of the clinical picture.ConclusionsPisa Syndrome, previously seen as a rare adverse effect, can occur as a dystonic reaction related to the use of psychotropic drugs, so its use should be judicious. Further studies are needed to understand the extent of this association and its pathophysiological mechanisms in order to guide more rigorous therapeutic lines.DisclosureNo significant relationships.
Los estilos APA, Harvard, Vancouver, ISO, etc.
14

Suzuki, Toshihito y Hisashi Matsuzaka. "Drug-Induced Pisa Syndrome (Pleurothotonus)". CNS Drugs 16, n.º 3 (2002): 165–74. http://dx.doi.org/10.2165/00023210-200216030-00003.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
15

DUGGAL, HARPREET S., SWAPNA SIVAMONY y CHANNAMALAPPA UMAPATHY. "Pisa Syndrome and Atypical Antipsychotics". American Journal of Psychiatry 161, n.º 2 (febrero de 2004): 373. http://dx.doi.org/10.1176/appi.ajp.161.2.373.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
16

Pan, Pei-Yin, Han-Wei Chou, Chih-Chieh Cheng, Yi-Chien Hsu y Nian-Sheng Tzeng. "Pisa Syndrome Induced by Paliperidone". Journal of Neuropsychiatry and Clinical Neurosciences 26, n.º 1 (enero de 2014): E07—E08. http://dx.doi.org/10.1176/appi.neuropsych.12110289.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
17

Bruneau, Marie-Andrée y Emmanuel Stip. "Metronome or alternating Pisa syndrome". International Clinical Psychopharmacology 13, n.º 5 (septiembre de 1998): 229–32. http://dx.doi.org/10.1097/00004850-199809000-00007.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
18

Li, Tien-Chun, Hsiu-Wen Chiu y Hung-Hui Liu. "Pisa Syndrome During Amisulpride Treatment". Journal of Neuropsychiatry and Clinical Neurosciences 22, n.º 3 (julio de 2010): 352.e27. http://dx.doi.org/10.1176/jnp.2010.22.3.352.e27.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
19

Pellene, Alejandro, Michel Saenz-Farret y Federico Micheli. "Recurrent and Alternating Pisa Syndrome". Clinical Neuropharmacology 38, n.º 6 (2015): 252–54. http://dx.doi.org/10.1097/wnf.0000000000000113.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
20

Sáenz-Farret, Michel, Alejandro Pellene y Federico Micheli. "Recurrent and Alternating Pisa Syndrome". Clinical Neuropharmacology 39, n.º 6 (2016): 337. http://dx.doi.org/10.1097/wnf.0000000000000183.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
21

Tinazzi, Michele, Alfonso Fasano, Christian Geroin, Francesca Morgante, Roberto Ceravolo, Simone Rossi, Astrid Thomas et al. "Pisa syndrome in Parkinson disease". Neurology 85, n.º 20 (21 de octubre de 2015): 1769–79. http://dx.doi.org/10.1212/wnl.0000000000002122.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
22

Saxena, Shekhar. "Tardive Dystonia and Pisa Syndrome". British Journal of Psychiatry 149, n.º 4 (octubre de 1986): 524. http://dx.doi.org/10.1192/bjp.149.4.524b.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
23

van Harten, P. R. "Pisa syndrome–a confusing term". British Journal of Psychiatry 160, n.º 3 (marzo de 1992): 424–25. http://dx.doi.org/10.1192/bjp.160.3.424b.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
24

Bhattacharya, K. F., I. Giannakikou, N. Munroe y K. Ray Chaudhuri. "Primary anticholinergic-responsive Pisa syndrome". Movement Disorders 15, n.º 6 (noviembre de 2000): 1285–87. http://dx.doi.org/10.1002/1531-8257(200011)15:6<1285::aid-mds1044>3.0.co;2-u.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
25

Davidson, Michael, Peter Powchik y Kenneth L. Davis. "Pisa syndrome in Alzheimer's disease". Biological Psychiatry 23, n.º 2 (enero de 1988): 213. http://dx.doi.org/10.1016/0006-3223(88)90095-9.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
26

Fichtner, Christopher G. "Pleurothotonus and the Pisa syndrome". Biological Psychiatry 31, n.º 5 (marzo de 1992): 534. http://dx.doi.org/10.1016/0006-3223(92)90269-6.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
27

Yassa, Ramzy. "The Pisa Syndrome: A Report of Two Cases". British Journal of Psychiatry 146, n.º 1 (enero de 1985): 93–95. http://dx.doi.org/10.1192/bjp.146.1.93.

Texto completo
Resumen
Ekbom et al (1972) described dystonic syndromes that appeared as a side-effect to treatment with the butyrophenone group of neuroleptic drugs. These symptoms consisted of tonic flexion of the trunk to one side, accompanied by its slight rotation, in the absence of other concomitant dystonic symptoms. They called this the ‘Pisa syndrome’. A literature survey of neuroleptic-included extrapyramidal side-effects gave little reference to this syndrome (Sovner & DiMascio, 1978; Berger & Rexworth, 1980), but two cases that fit the description of this side-effect are presented here.
Los estilos APA, Harvard, Vancouver, ISO, etc.
28

Erdem, Nazan Şimşek y Sehur Sibel Özkaynak. "Chronic form of Pisa syndrome after prolonged exposure to low-dose amisulpride treatment". Ideggyógyászati szemle 74, n.º 9-10 (2021): 356–60. http://dx.doi.org/10.18071/isz.74.0356.

Texto completo
Resumen
Pisa syndrome is a movement problem defined by tonic, sustained lateral flexion with a slight posterior rotation of the trunk. It seems to be a side effect of antipsychotic medicine in most cases. The clinical duration of Pisa syndrome can be acute, chronic, or recurrent. As far as we know, no reports are available in the literature on the chronic form of Pisa syndrome caused by low-dose amisulpride. A case of refractory tardive dystonia form of Pisa syndrome during treatment with stable low-dose amisulpride is presented in this report. Long-term, low-dosage amisulpride therapy may induce tardive dystonia even in patients with no other risk factors for dystonia.
Los estilos APA, Harvard, Vancouver, ISO, etc.
29

Mahmoud, Imene, Mouna Aissi, Narjes Mokni, Rim Masmoudi, Nizar Daoussi y Mahbouba Frih-Ayed. "Syndrome de la tour de Pise (Pisa syndrome)". Revue Neurologique 173 (marzo de 2017): S153. http://dx.doi.org/10.1016/j.neurol.2017.01.282.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
30

Santos, H., E. Dornelles, J. Pereira y A. Vieira. "What is the Pisa Syndrome? A review". European Psychiatry 65, S1 (junio de 2022): S725. http://dx.doi.org/10.1192/j.eurpsy.2022.1872.

Texto completo
Resumen
Introduction Pisa syndrome (PS) is a type of dystonia of rare occurrence, first described in 1972 as an adverse effect of neuroleptic agents. It is used to describe a postural abnormality that includes trunk flexion in the coronal plane and axial rotation, which improves in the supine position. Objectives In this work, we aim to conduct a brief review of Pisa Syndrome aetiology, pathophysiology and treatment. Methods A non-systematic search was conducted through the PubMed database for “pisa syndrome”. Articles were screened for relevant information on PS aetiology, pathophysiology and treatment. Results Pisa syndrome has been associated as an adverse effect of multiple drugs from different classes, mainly antipsychotics, dopaminergic agents and cholinesterase inhibitors. The underlying mechanisms are not yet fully understood. Nevertheless, one of the most consensual hypothesis considers PS as a consequence of a cholinergic-dopaminergic imbalance that can be caused by antipsychotic treatment. Some factors have been associated with increased risk for developing PS such as old age and polypharmacy. PS appears to be better treated with the reduction or interruption of the agent(s) associated with its onset. Conclusions Despite its low incidence, Pisa syndrome can occur as a side effect of a number of different medications and the identification of the trigger-drug is fundamental so it can be reduced or interrupted in order to treat this condition. Disclosure No significant relationships.
Los estilos APA, Harvard, Vancouver, ISO, etc.
31

Praharaj, Samir Kumar y Manu Arora. "Pisa Syndrome: Acute and Tardive Forms". Southern Medical Journal 100, n.º 8 (agosto de 2007): 853–54. http://dx.doi.org/10.1097/smj.0b013e3180f615a5.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
32

Villarejo, Alberto, Ana Camacho, Rocío García–Ramos, Teresa Moreno, Marta Penas, Raúl Juntas y Juan Ruiz. "Cholinergic–Dopaminergic Imbalance in Pisa Syndrome". Clinical Neuropharmacology 26, n.º 3 (mayo de 2003): 119–21. http://dx.doi.org/10.1097/00002826-200305000-00004.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
33

Hung, Tai-Hsin, Yu Lee, Yung-Yee Chang, Mian-Yoon Chong y Pao-Yen Lin. "Reversible Pisa Syndrome Induced by Clozapine". Clinical Neuropharmacology 30, n.º 6 (noviembre de 2007): 370–72. http://dx.doi.org/10.1097/wnf.0b013e31805930e3.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
34

Walder, Alice, Waldemar Greil y Pierre Baumann. "Drug-induced Pisa syndrome under quetiapine". Progress in Neuro-Psychopharmacology and Biological Psychiatry 33, n.º 7 (octubre de 2009): 1286–87. http://dx.doi.org/10.1016/j.pnpbp.2009.07.024.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
35

Scocco, Darío H., Judith N. Wagner, Juan Racosta, Anabel Chade y Oscar S. Gershanik. "Subjective visual vertical in Pisa syndrome". Parkinsonism & Related Disorders 20, n.º 8 (agosto de 2014): 878–83. http://dx.doi.org/10.1016/j.parkreldis.2014.04.030.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
36

Amore, M., M. Cerisoli, S. Campanile y A. Campanile. "Pisa syndrome. Report of a case". Italian Journal of Neurological Sciences 9, n.º 3 (junio de 1988): 273–74. http://dx.doi.org/10.1007/bf02334052.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
37

Padberg, F., S. Stübner, K. Buch, U. Hegerl y H. Hampel. "Pisa syndrome during treatment with sertindole". British Journal of Psychiatry 173, n.º 4 (octubre de 1998): 351–52. http://dx.doi.org/10.1192/bjp.173.4.351b.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
38

Suzuki, T., J. Koizumi, T. Moroji, K. Sakuma, M. Hori y T. Hori. "Clinical characteristics of the Pisa syndrome". Acta Psychiatrica Scandinavica 82, n.º 6 (diciembre de 1990): 454–57. http://dx.doi.org/10.1111/j.1600-0447.1990.tb03078.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
39

Iuppa, Courtney A. y Lauren A. Diefenderfer. "Risperidone-Induced Pisa Syndrome in MS". Annals of Pharmacotherapy 47, n.º 9 (septiembre de 2013): 1223–28. http://dx.doi.org/10.1177/1060028013503132.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
40

Tsou, Chang-Chih y San-Yuan Huang. "Olanzapine as a possible replacement choice for paliperidone-induced Pisa syndrome: a case report". Australasian Psychiatry 24, n.º 6 (26 de septiembre de 2016): 545–47. http://dx.doi.org/10.1177/1039856216665285.

Texto completo
Resumen
Objective: The aim of this paper is to present a case of paliperidone-induced Pisa syndrome and provide treatment experience. Method: The case report is combined with a review of the literature. Results: A 37-year-old man had been diagnosed with paranoid-type schizophrenia for about 10 years. He received three-month treatment of paliperidone extended release (ER) at 6 mg per day, but showed a progressively Pisa-like physical position. We initially added an anticholinergic drug, but saw no improvement. The paliperidone ER was replaced by olanzapine at 10 mg per day, and the Pisa-like symptom improved after 1 month of the drug replacement. Conclusions: We propose olanzapine as a possible replacement choice for patients with paliperidone-related Pisa syndrome.
Los estilos APA, Harvard, Vancouver, ISO, etc.
41

Miletić, Vladimir, Boris Radić y Maja Relja. "Acute Pisa Syndrome as a Neurological Emergency". Journal of Neuropsychiatry and Clinical Neurosciences 27, n.º 2 (abril de 2015): e159-e160. http://dx.doi.org/10.1176/appi.neuropsych.14050105.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
42

Wu, Pei-Chuan, I.-Shin Shiah, Wen-Kuei Lee, Chun-Yen Chen, Yu-Cheng Kao y Ming-Kuen Chou. "Amisulpride-associated acute Pisa syndrome in schizophrenia". Acta Neuropsychiatrica 22, n.º 3 (junio de 2010): 163–64. http://dx.doi.org/10.1111/j.1601-5215.2010.00462.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
43

Wölfl, H. Rittmannsberger, H. "Pisa syndrome (pleurothotonus) in a polytoxicomanic patient". International Journal of Psychiatry in Clinical Practice 5, n.º 2 (enero de 2001): 145–47. http://dx.doi.org/10.1080/136515001300375352.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
44

Kropp, Stefan, Ute Hauser, Hinderk M. Emrich y Renate Grohmann. "Metoclopramide-Related Pisa Syndrome in Clozapine Treatment". Journal of Neuropsychiatry and Clinical Neurosciences 13, n.º 3 (agosto de 2001): 427–28. http://dx.doi.org/10.1176/jnp.13.3.427.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
45

Ziegenbein, Marc, Georg Schomerus y Stefan Kropp. "Ziprasidone-Induced Pisa Syndrome after Clozapine Treatment". Journal of Neuropsychiatry and Clinical Neurosciences 15, n.º 4 (noviembre de 2003): 458–59. http://dx.doi.org/10.1176/jnp.15.4.458.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
46

Nishimura, Katsuji, Yuri Mikami, Seiichi Tsuchibuchi y Naoshi Horikawa. "Pisa Syndrome Resolved After Switching to Olanzapine". Journal of Neuropsychiatry and Clinical Neurosciences 19, n.º 2 (abril de 2007): 202–3. http://dx.doi.org/10.1176/jnp.2007.19.2.202.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
47

Arora, Manu, Samir Kumar Praharaj y Sukanto Sarkar. "Clozapine Effective in Olanzapine-Induced Pisa Syndrome". Annals of Pharmacotherapy 40, n.º 12 (diciembre de 2006): 2273–75. http://dx.doi.org/10.1345/aph.1h325.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
48

Suzuki, Toshihito, Hirofumi Kurita, Takafumi Hori, Megumi Sasaki, Atsuomi Baba, Hiroyasu Shiraishi y John E. Piletz. "The pisa syndrome (pleurothotonus) during antidepressant therapy". Biological Psychiatry 41, n.º 2 (enero de 1997): 234–36. http://dx.doi.org/10.1016/s0006-3223(96)00405-2.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
49

Todisco, Massimiliano, Nicolò Gabriele Pozzi, Roberta Zangaglia, Brigida Minafra, Domenico Servello, Roberto Ceravolo, Enrico Alfonsi, Alfonso Fasano y Claudio Pacchetti. "Pisa syndrome in Idiopathic Normal Pressure Hydrocephalus". Parkinsonism & Related Disorders 66 (septiembre de 2019): 40–44. http://dx.doi.org/10.1016/j.parkreldis.2019.06.024.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
50

Galati, Salvatore, Jens Carsten Möller y Claudio Städler. "Ropinirole-Induced Pisa Syndrome in Parkinson Disease". Clinical Neuropharmacology 37, n.º 2 (2014): 58–59. http://dx.doi.org/10.1097/wnf.0000000000000022.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!

Pasar a la bibliografía